Global In Vitro Toxicology Testing Market Report and Forecast 2025-2034

Global In Vitro Toxicology Testing Market Outlook

The global in vitro toxicology testing market size reached nearly USD 28.29 billion in 2024. The market is expected to grow at a CAGR of 11.30% between 2025 and 2034, reaching a value of about USD 74.13 billion by 2034.

Key Trends in the Market

In vitro toxicology testing refers to a testing method that is used to demonstrate the safety of pharmaceutical drugs, medical devices, chemicals, and cosmetic products, among others. It accelerates product development and drives customer safety while establishing the toxicological profiles of cosmetics, biopharmaceuticals, and medical devices.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

• The increasing drug discovery and development activities are expected to surge the use of in vitro toxicology assays to investigate the potential use of new drugs, determine the safety profile of a drug, and provide an opportunity for researchers to improve the properties of a drug before its clinical trial.

• Some of the major in vitro toxicology testing market drivers include the rising demand to support bioanalytical, toxicokinetic, and metabolic applications and assess skin corrosion, skin irritation, and skin sensitisation models, and the increasing attempts to address challenges associated with traditional chemical assessment techniques.

• Due to the surging concerns regarding animal welfare and ethics, in vitro toxicology testing is increasingly used as an alternative method to reduce the use of traditional animal-based toxicology testing in various applications.

• With rapid biotechnological advancements, the development of reproducible, reliable, and rapid in vitro toxicology assays is anticipated to surge in the forecast period.

Market Analysis

Based on product type, the in vitro toxicology testing market segmentation includes equipment, assay kits, consumables, software, and services. The market, by technology, is divided into high throughput, cell culture, and toxicogenomics. By method, the market is segmented into cellular assay, biochemical assay, in silica, and ex-vivo. On the basis of application, the market is classified into neuro toxicity, dermal toxicity, and cytotoxicity, among others.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

By end-user, the market is divided into pharmaceuticals and biopharmaceuticals, cosmetics and household products, food industry, and chemicals, among others. The regional markets for in vitro toxicology testing can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global in vitro toxicology testing market, covering their competitive landscape and latest developments like mergers, acquisitions, investments and expansion plans.

• SGS SA

• Gentronix

• Thermo Fisher Scientific Inc.

• Bio-Rad Laboratories, Inc.

• Integrated Laboratory Systems

• LAUS GmbH

• Aragen Life Sciences Pvt. Ltd.

• Others

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Purchase the Regional Overview for USD 1099

If you choose to purchase the full report at a later stage, the amount already paid will be adjusted, and you will only need to pay the remaining balance.

Market Share by End-User

In vitro toxicology is used to test the presence of toxic ingredients in cosmetic and household products, along with their efficacy. In the cosmetics industry, in vitro toxicology testing is integral to ensure the safety of cosmetic formulations and achieve regulatory approval for new product launches.

To meet the stringent regulatory requirements, various cosmetic players are partnering with laboratories to develop in vitro assays that can address relevant skincare and personal care toxicology concerns, like percutaneous penetration, skin irritation, as well as photo-toxicity, among others.

Additionally, the in vitro toxicology testing market is being aided by the growing focus on toxicology testing of chemicals migrating from food contact articles (FCAs) into food. As regulations requiring safety assessment for substances migrating from food contact materials are increasing, the use of in vitro bioassays to evaluate the toxicity of food contact articles and materials is likely to grow in upcoming years.

Meanwhile, in vitro toxicology testing is widely used in biopharmaceutical and pharmaceutical drug development and discovery, to maximise safety in clinical trials at a reasonable cost. The increasing issues associated with cardiotoxicity, hepatoxicity, and genotoxicity are also expected to boost in vitro testing demand in drug discovery and development in the forecast period.

In Vitro Toxicology Testing Market Share by Product Type

In vitro toxicology assays are increasingly used as alternatives to traditional animal-based toxicity testing while supporting toxicokinetic, metabolic, and bioanalytical investigations with quantitative and qualitative data. Leading players in the market are developing new and innovative in vitro toxicology assays for screening and profiling applications.

Besides, there is a growing demand for in vitro toxicology testing services that offer enhanced quality, cost-effectiveness, flexible solutions, reproducible data, and fast turnaround times. Key players also offer innovative in vitro toxicology testing services, including neurotoxicity and nephrotoxicity testing, to help investigate drug-drug interactions and safety assessments.

Further, the in vitro toxicology testing market is likely to benefit from the growing demand for software that provides reliable toxicity knowledgebase, an easy-to-use interface, and toxicology and chemistry searches to enable toxicologists to build an interactive workflow, save time to retrieve crucial toxicological data, and easily assess genotoxic impurities in products.

Competitive Landscape

SGS SA is a leading inspection, testing, and certification company that provides specialised solutions to enable businesses to become simpler, more efficient, and faster. It unifies various sustainability services to provide enhanced visibility to several services for supporting customers and providing a positive impact on the planet. It aims to develop a more interconnected world by helping new technology reach consumers more affordably and quickly.

Gentronix is a UK-based company that is focused on providing predictive toxicology services and products to the chemical sector. It actively collaborates with various companies to deliver innovative solutions for skin sensitisation and genetic toxicology. The company also offers various rapid turnaround screens, flow cytometry services, mouse lymphoma, and in vitro micronucleus studies for demonstrating chemical safety and addressing regulatory challenges.

Thermo Fisher Scientific Inc. is a leading company that offers equipment, instrument, consumables, and services to enable scientists to solve complex analytical challenges in clinical laboratories and biotechnology, pharmaceutical, government, industrial, and environmental research. The product areas of the company include microarray analysis, single-use bioprocessing, lab plasticware and supplies, and sequencing, among others.

Other major players in the in vitro toxicology testing market include Bio-Rad Laboratories, Inc., Integrated Laboratory Systems, LAUS GmbH, and Aragen Life Sciences Pvt. Ltd., among others.

Key Highlights of the Report